Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

A step forward in the treatment of multidrug-resistant tuberculosis.

Ridzon R, Castro KG.

Int J Tuberc Lung Dis. 2019 May 1;23(5):533-534. doi: 10.5588/ijtld.19.0208. No abstract available.

PMID:
31097059
2.

Progress in voluntary medical male circumcision for HIV prevention supported by the US President's Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectional programme data.

Davis SM, Hines JZ, Habel M, Grund JM, Ridzon R, Baack B, Davitte J, Thomas A, Kiggundu V, Bock N, Pordell P, Cooney C, Zaidi I, Toledo C.

BMJ Open. 2018 Sep 1;8(8):e021835. doi: 10.1136/bmjopen-2018-021835.

3.

Systematic review of the effect of economic compensation and incentives on uptake of voluntary medical male circumcision among men in sub-Saharan Africa.

Carrasco MA, Grund JM, Davis SM, Ridzon R, Mattingly M, Wilkinson J, Kasdan B, Kiggundu V, Njeuhmeli E.

AIDS Care. 2018 Sep;30(9):1071-1082. doi: 10.1080/09540121.2018.1453921. Epub 2018 Mar 22.

4.

Bleeding and Blood Disorders in Clients of Voluntary Medical Male Circumcision for HIV Prevention - Eastern and Southern Africa, 2015-2016.

Hinkle LE, Toledo C, Grund JM, Byams VR, Bock N, Ridzon R, Cooney C, Njeuhmeli E, Thomas AG, Odhiambo J, Odoyo-June E, Talam N, Matchere F, Msungama W, Nyirenda R, Odek J, Come J, Canda M, Wei S, Bere A, Bonnecwe C, Choge IA, Martin E, Loykissoonlal D, Lija GJI, Mlanga E, Simbeye D, Alamo S, Kabuye G, Lubwama J, Wamai N, Chituwo O, Sinyangwe G, Zulu JE, Ajayi CA, Balachandra S, Mandisarisa J, Xaba S, Davis SM.

MMWR Morb Mortal Wkly Rep. 2018 Mar 23;67(11):337-339. doi: 10.15585/mmwr.mm6711a6.

5.

The tip of the iceberg.

Ridzon R.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):237. doi: 10.5588/ijtld.17.0865. No abstract available.

PMID:
29471897
6.

Test and treat for TB-HIV.

Ridzon R.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1208. doi: 10.5588/ijtld.17.0728. No abstract available.

7.

Interventions to Drive Uptake of Voluntary Medical Male Circumcision-A Collection of Impact Evaluation Evidence.

Sgaier SK, Reed JB, Sundaram M, Brown A, Djimeu E, Ridzon R.

J Acquir Immune Defic Syndr. 2016 Oct 1;72 Suppl 4:S257-S261. No abstract available.

8.

Employing Demand-Based Volumetric Forecasting to Identify Potential for and Roles of Devices in Scale-Up of Medical Male Circumcision in Zambia and Zimbabwe.

Fram F, Church F, Sundaram M, Sgaier SK, Ridzon R, Eletskaya M, Nanga A, Gumede-Moyo S, Tambatamba B, Mugurungi O, Ncube G, Xabayu S, Odawo P, Kretschmer S.

J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S83-9. doi: 10.1097/QAI.0000000000000991.

9.

Innovative Methods of Male Circumcision for HIV Prevention-Getting the Right Evidence.

Samuelson J, Hargreave T, Ridzon R, Farley T.

J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S5-S12. doi: 10.1097/QAI.0000000000000738.

10.

VMMC Devices-Introducing a New Innovation to a Public Health Intervention.

Ridzon R, Reed JB, Sgaier SK, Hankins C.

J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S1-4. doi: 10.1097/QAI.0000000000000967. No abstract available.

11.

Notes from the Field: Tetanus Cases After Voluntary Medical Male Circumcision for HIV Prevention--Eastern and Southern Africa, 2012-2015.

Grund JM, Toledo C, Davis SM, Ridzon R, Moturi E, Scobie H, Naouri B, Reed JB, Njeuhmeli E, Thomas AG, Benson FN, Sirengo MW, Muyenzi LN, Lija GJ, Rogers JH, Mwanasalli S, Odoyo-June E, Wamai N, Kabuye G, Zulu JE, Aceng JR, Bock N.

MMWR Morb Mortal Wkly Rep. 2016 Jan 22;65(2):36-7. doi: 10.15585/mmwr.mm6502a5.

12.

Voluntary medical male circumcision: an HIV prevention priority for PEPFAR.

Reed JB, Njeuhmeli E, Thomas AG, Bacon MC, Bailey R, Cherutich P, Curran K, Dickson K, Farley T, Hankins C, Hatzold K, Justman J, Mwandi Z, Nkinsi L, Ridzon R, Ryan C, Bock N.

J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S88-95. doi: 10.1097/QAI.0b013e31825cac4e. Review.

13.

Epidemic Intelligence Service investigations of respiratory illness, 1946-2005.

Hadler SC, Castro KG, Dowdle W, Hicks L, Noble G, Ridzon R.

Am J Epidemiol. 2011 Dec 1;174(11 Suppl):S36-46. doi: 10.1093/aje/kwr309.

PMID:
22135392
14.

Antiretroviral therapy in prevention of HIV and TB: update on current research efforts.

Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, Simao M, Hankins C, Schwartlander B, Ridzon R, Bazin B, Williams B, Lo YR, McClure C, Montaner J, Hirnschall G; ART in Prevention of HIV and TB Research Writing Group.

Curr HIV Res. 2011 Sep;9(6):446-69. Review.

15.

Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?

Loeliger A, Suthar AB, Ripin D, Glaziou P, O'Brien M, Renaud-Thery F, Crowley S, Williams B, Ridzon R, Granich R, Gilks C.

Int J Tuberc Lung Dis. 2012 Jan;16(1):6-15. doi: 10.5588/ijtld.10.0626. Epub 2011 Aug 3. Review.

PMID:
21819645
16.

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Magaret AS, Wang RS, Kidoguchi L, Barnes L, Ridzon R, Corey L, Celum C; Partners in Prevention HSV/HIV Transmission Study Team.

Lancet. 2010 Mar 6;375(9717):824-33. doi: 10.1016/S0140-6736(09)62038-9. Epub 2010 Feb 12.

17.

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Stevens W, Campbell MS, Thomas KK, Coombs RW, Morrow R, Whittington WL, McElrath MJ, Barnes L, Ridzon R, Corey L; Partners in Prevention HSV/HIV Transmission Study Team.

N Engl J Med. 2010 Feb 4;362(5):427-39. doi: 10.1056/NEJMoa0904849. Epub 2010 Jan 20.

18.

Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial.

Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, Nalugoda F, Buwembo D, Ssempijja V, Kiwanuka N, Moulton LH, Sewankambo NK, Reynolds SJ, Quinn TC, Opendi P, Iga B, Ridzon R, Laeyendecker O, Gray RH.

Lancet. 2009 Jul 18;374(9685):229-37. doi: 10.1016/S0140-6736(09)60998-3.

19.

Male circumcision for the prevention of HSV-2 and HPV infections.

Ridzon R, Singh K.

N Engl J Med. 2009 Jul 16;361(3):307; author reply 307-8. No abstract available.

PMID:
19610160
20.

Sexual satisfaction of women partners of circumcised men in a randomized trial of male circumcision in Rakai, Uganda.

Kigozi G, Lukabwe I, Kagaayi J, Wawer MJ, Nantume B, Kigozi G, Nalugoda F, Kiwanuka N, Wabwire-Mangen F, Serwadda D, Ridzon R, Buwembo D, Nabukenya D, Watya S, Lutalo T, Nkale J, Gray RH.

BJU Int. 2009 Dec;104(11):1698-701. doi: 10.1111/j.1464-410X.2009.08683.x. Epub 2009 Jun 12.

21.

In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?

Lavery JV, Singer PA, Ridzon R, Singh JA, Slutsky AS, Anisko JJ, Buchanan D.

PLoS Med. 2009 Jun 9;6(6):e1000071. doi: 10.1371/journal.pmed.1000071. Epub 2009 Jun 9.

22.

The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda.

Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, Watya S, Moulton L, Chen MZ, Sewankambo NK, Kiwanuka N, Sempijja V, Lutalo T, Kagayii J, Wabwire-Mangen F, Ridzon R, Bacon M, Wawer MJ.

Am J Obstet Gynecol. 2009 Jan;200(1):42.e1-7. doi: 10.1016/j.ajog.2008.07.069. Epub 2008 Oct 30.

23.

The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda.

Kigozi G, Gray RH, Wawer MJ, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Ridzon R, Opendi P, Sempijja V, Settuba A, Buwembo D, Kiggundu V, Anyokorit M, Nkale J, Kighoma N, Charvat B.

PLoS Med. 2008 Jun 3;5(6):e116. doi: 10.1371/journal.pmed.0050116.

24.

Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial.

Peterson L, Taylor D, Roddy R, Belai G, Phillips P, Nanda K, Grant R, Clarke EE, Doh AS, Ridzon R, Jaffe HS, Cates W.

PLoS Clin Trials. 2007 May 25;2(5):e27.

25.

Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics.

Aledort JE, Ronald A, Rafael ME, Girosi F, Vickerman P, Le Blancq SM, Landay A, Holmes K, Ridzon R, Hellmann N, Shea MV, Peeling RW.

Nature. 2006 Nov 23;444 Suppl 1:59-72. No abstract available.

PMID:
17159895
26.

Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics.

Aledort JE, Ronald A, Le Blancq SM, Ridzon R, Landay A, Rafael ME, Shea MV, Safrit J, Peeling RW, Hellmann N, Mwaba P, Holmes K, Wilfert C.

Nature. 2006 Nov 23;444 Suppl 1:19-28. No abstract available.

PMID:
17159891
27.

Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.

Jensen PA, Lambert LA, Iademarco MF, Ridzon R; CDC.

MMWR Recomm Rep. 2005 Dec 30;54(RR-17):1-141.

28.

Optimal latent TB control methods.

Ridzon R.

Int J Tuberc Lung Dis. 2005 Mar;9(3):236. No abstract available.

PMID:
15786884
29.

Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients.

Li J, Burzynski JN, Lee YA, Berg D, Driver CR, Ridzon R, Munsiff SS.

Chest. 2004 Dec;126(6):1770-6.

PMID:
15596672
30.

HIV infection in TB patients: money in the bank.

Ridzon R.

Int J Tuberc Lung Dis. 2004 Aug;8(8):923. No abstract available.

PMID:
15305472
31.

A network-informed approach to investigating a tuberculosis outbreak: implications for enhancing contact investigations.

McElroy PD, Rothenberg RB, Varghese R, Woodruff R, Minns GO, Muth SQ, Lambert LA, Ridzon R.

Int J Tuberc Lung Dis. 2003 Dec;7(12 Suppl 3):S486-93.

PMID:
14677842
32.

Potential nosocomial exposure to Mycobacterium tuberculosis from a bronchoscope.

Larson JL, Lambert L, Stricof RL, Driscoll J, McGarry MA, Ridzon R.

Infect Control Hosp Epidemiol. 2003 Nov;24(11):825-30.

PMID:
14649770
33.

A no-name tuberculosis tracking system.

Kim DY, Ridzon R, Giles B, Mireles T, Garrity K, Hathcock AL, Crowder D, Jackson R, Taylor Z.

Am J Public Health. 2003 Oct;93(10):1637-9.

34.

Extensive transmission of Mycobacterium tuberculosis among congregated, HIV-infected prison inmates in South Carolina, United States.

McLaughlin SI, Spradling P, Drociuk D, Ridzon R, Pozsik CJ, Onorato I.

Int J Tuberc Lung Dis. 2003 Jul;7(7):665-72.

PMID:
12870688
35.

Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001.

Griffith KS, Mead P, Armstrong GL, Painter J, Kelley KA, Hoffmaster AR, Mayo D, Barden D, Ridzon R, Parashar U, Teshale EH, Williams J, Noviello S, Perz JF, Mast EE, Swerdlow DL, Hadler JL.

Emerg Infect Dis. 2003 Jun;9(6):681-8.

36.

Outbreak of tuberculosis among homeless persons coinfected with human immunodeficiency virus.

McElroy PD, Southwick KL, Fortenberry ER, Levine EC, Diem LA, Woodley CL, Williams PM, McCarthy KD, Ridzon R, Leone PA.

Clin Infect Dis. 2003 May 15;36(10):1305-12. Epub 2003 May 9.

PMID:
12746777
37.

Limited transmission of multidrug-resistant tuberculosis.

Spradling P, Ridzon R, Nitta AT, Kim J.

Am J Respir Crit Care Med. 2003 Feb 1;167(3):473; author reply 473-4. No abstract available.

PMID:
12554633
38.

Pseudo-outbreak of tuberculosis in poultry plant workers, Sussex County, Delaware.

Kim DY, Ridzon R, Giles B, Mireles T.

J Occup Environ Med. 2002 Dec;44(12):1169-72.

PMID:
12500459
39.

Use of DNA fingerprinting to investigate a multiyear, multistate tuberculosis outbreak.

McElroy PD, Sterling TR, Driver CR, Kreiswirth B, Woodley CL, Cronin WA, Hardge DX, Shilkret KL, Ridzon R.

Emerg Infect Dis. 2002 Nov;8(11):1252-6.

40.

Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.

Williams JL, Noviello SS, Griffith KS, Wurtzel H, Hamborsky J, Perz JF, Williams IT, Hadler JL, Swerdlow DL, Ridzon R.

Emerg Infect Dis. 2002 Oct;8(10):1133-7.

41.

Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.

Shepard CW, Soriano-Gabarro M, Zell ER, Hayslett J, Lukacs S, Goldstein S, Factor S, Jones J, Ridzon R, Williams I, Rosenstein N; CDC Adverse Events Working Group.

Emerg Infect Dis. 2002 Oct;8(10):1124-32.

42.

Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001.

Williams AA, Parashar UD, Stoica A, Ridzon R, Kirschke DL, Meyer RF, McClellan J, Fischer M, Nelson R, Cartter M, Hadler JL, Jernigan JA, Mast EE, Swerdlow DL; Connecticut Anthrax Investigation Team.

Emerg Infect Dis. 2002 Oct;8(10):1078-82.

43.

Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak.

Spradling P, Drociuk D, McLaughlin S, Lee LM, Peloquin CA, Gallicano K, Pozsik C, Onorato I, Castro KG, Ridzon R.

Clin Infect Dis. 2002 Nov 1;35(9):1106-12. Epub 2002 Oct 10.

PMID:
12384845
44.

An investigation of suspected exogenous reinfection in tuberculosis patients in Kampala, Uganda.

Fitzpatrick LK, Okwera A, Mugerwa R, Ridzon R, Ehiner J, Onorato I.

Int J Tuberc Lung Dis. 2002 Jun;6(6):550-2.

PMID:
12068990
45.

The place of prevention in HIV clinical care: a roundtable discussion.

O'Rourke M, Auerbach J, del Rio C, Dooley S, Friedland G, Ridzon R.

AIDS Clin Care. 2002 Jun;14(6):49-53, 58. No abstract available.

PMID:
12061143
46.

A preventable outbreak of tuberculosis investigated through an intricate social network.

Fitzpatrick LK, Hardacker JA, Heirendt W, Agerton T, Streicher A, Melnyk H, Ridzon R, Valway S, Onorato I.

Clin Infect Dis. 2001 Dec 1;33(11):1801-6. Epub 2001 Oct 24.

PMID:
11692291
47.

Sputum induction versus fiberoptic bronchoscopy in the diagnosis of tuberculosis.

Larson JL, Ridzon R, Hannan MM.

Am J Respir Crit Care Med. 2001 Apr;163(5):1279-80. No abstract available.

PMID:
11316673
48.

Outbreak of multidrug-resistant tuberculosis at a methadone treatment program.

Conover C, Ridzon R, Valway S, Schoenstadt L, McAuley J, Onorato I, Paul W.

Int J Tuberc Lung Dis. 2001 Jan;5(1):59-64.

PMID:
11263518
49.

A multi-state outbreak of tuberculosis among members of a highly mobile social network: implications for tuberculosis elimination.

Sterling TR, Thompson D, Stanley RL, McElroy PD, Madison A, Moore K, Ridzon R, Harrington S, Bishai WR, Chaisson RE, Bur S.

Int J Tuberc Lung Dis. 2000 Nov;4(11):1066-73.

PMID:
11092720
50.

Practice guidelines for the treatment of tuberculosis.

Horsburgh CR Jr, Feldman S, Ridzon R; Infectious Diseases Society of America.

Clin Infect Dis. 2000 Sep;31(3):633-9. Epub 2000 Oct 4. No abstract available.

PMID:
11017808

Supplemental Content

Loading ...
Support Center